Roche Holding reported 22.04B in Gross Profit on Sales for its second fiscal semester of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Gross Profit On Sales Change
Alcon AG ALC:SW USD 1.17B 5M
Amgen AMGN:US USD 5.09B 28M
Artemis Alpha ATS:LN GBP -26370000 16.4M
AstraZeneca AZN:LN USD 8.7B 168M
Bayer BAYN:GR EUR 7.23B 198M
Biogen BIIB:US USD 1.97B 65.9M
Bristol Myers Squibb BMY:US USD 8.89B 21M
Eli Lilly And LLY:US USD 5.75B 391.2M
Fresenius FRE:GR EUR 2.78B 79M
Fresenius Medical Care FME:GR EUR 1.35B 10.59M
Gilead Sciences GILD:US USD 5.99B 346M
GlaxoSmithKline GSK:LN GBP 5.2B 244M
Hikma Pharmaceutical HIK:LN USD 642M 19M
Merck MRK:GR EUR 3.38B 283M
Merk MRK:US USD 10.47B 610M
Novartis NOVN:VX USD 9.16B 21M
Orion ORNBV:FH EUR 155.2M 200.5M
Pfizer PFE:US USD 14.47B 2.08B
Philips PHIA:NA EUR 2.22B 491M
Recordati REC:IM EUR 330.13M 9.42M
Regeneron Pharmaceuticals REGN:US USD 2.87B 255.4M
Roche Holding ROG:VX 22.04B 696M